The use of sequential pharmacotherapy for the treatment of acute major depression: a scoping review-Reference-Cited by-同舟云学术

The use of sequential pharmacotherapy for the treatment of acute major depression: a scoping review

Published:2021-02-22 Issue:8 Volume:22 Page:1005-1014
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Jones Brett D.M.¹^ORCID,Husain M. Ishrat¹²^ORCID,Mulsant Benoit H.¹³

Affiliation:

1. Department of Psychiatry, University of Toronto, Toronto, Canada

2. General Adult Psychiatry and Health Systems Division, Centre for Addiction and Mental Health, Toronto, Canada

3. Adult Neurodevelopmental and Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, Canada

Funder

Department of Psychiatry, University of Toronto

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1878144

Reference80 articles.

1. The World Health Organization. Depression and other common mental disorders: global health estimates. Geneva. 2017

2. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial

3. The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature

4. Economic Burden of Depression and Associated Resource Use in Manitoba, Canada

5. Association AP Diagnostic and statistical manual of mental disorders: DSM-5. 2013 [cited 2020 Apr 22]; Available from: https://www.academia.edu/download/38718268/CSL6820_21.pdf

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum indoleamine 2, 3-dioxygenase and tryptophan-2, 3-dioxygenase: potential biomarkers for the diagnosis of major depressive disorder;Psychopharmacology;2024-01-30

2. Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence;Psychiatry Research;2022-01